Celltrion, Inc. is a leading South Korean biopharmaceutical company specializing in the research, development, and manufacturing of innovative biologics and biosimilars. Founded in 2002 and headquartered in Incheon, South Korea, the company has established itself as a global player in the biotechnology industry, with a mission to improve access to advanced therapeutics and enhance patient quality of life worldwide. Celltrion is particularly renowned for its portfolio of biosimilar monoclonal antibodies, which offer cost-effective alternatives to existing biologic treatments for conditions such as cancer, autoimmune diseases, and infectious diseases.
With a workforce of over 2,000 employees and operations spanning multiple continents, Celltrion has built a strong reputation for scientific excellence, regulatory compliance, and large-scale biopharmaceutical manufacturing capabilities. The company has achieved significant milestones, including the development of the world’s first monoclonal antibody biosimilar approved by the European Medicines Agency. In recent years, Celltrion has expanded its pipeline to include novel biologics, COVID-19 treatments, and next-generation biosimilars, further solidifying its position as a key innovator in global healthcare.
No open positions at Celltrion right now. Check back later!
Browse All Jobs →